Northwestern Mutual Wealth Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Other funds holding NKTR
RCM
DTC
MAM
Northwestern Mutual Wealth Management's NKTR Position: Q3 2023 in Review
Northwestern Mutual Wealth Management sold out of Nektar Therapeutics (NKTR) in Q3 2023, closing a stake of 13 shares — an estimated $115 sold.
Northwestern Mutual Wealth Management first reported a position in NKTR in Q4 2014 and held it in 19 quarters. The position peaked at $47K in Q3 2021. 138 funds tracked by Wall St. Rank hold NKTR as of Q3 2023.
- Northwestern Mutual Wealth Management reported no remaining Nektar Therapeutics position as of Q3 2023 after selling out during the quarter.
- Northwestern Mutual Wealth Management sold 13 Nektar Therapeutics shares in Q3 2023, an estimated $115.
- Northwestern Mutual Wealth Management first reported a position in Nektar Therapeutics in Q4 2014 and held it in 19 quarters.
- Northwestern Mutual Wealth Management's Nektar Therapeutics position peaked at $47K in Q3 2021.
- 138 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2023.
Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.